Moving too quickly in the product development process can lead to mistakes.
Part three of this series discusses the key defenses available to each element of a lawsuit against providers and labs.
The pandemic is helping realize the potential of ISO IDMP data standards in relation to adverse event reporting, electronic prescribing and medicines control in the supply chain.
Under the new regulation, medtech manufacturers can no longer defend their claims with limited clinical data; the depth, breadth and scrutiny on clinical data is much more rigorous.
To achieve success in this market, device manufacturers should consider working with providers to help contain costs and enhance outcomes.
Achieving EU MDR compliance is considerably challenging for many businesses, which is why they must be discerning when it comes to selecting suitable partners.
Leveraging automation and data analytics can help facilitate innovation and financial stability.
Part II reviews some lessons learned as we try to predict the trajectory and defenses to COVID-19 test cases.
Monitoring patients through distributed technology will be key to restoring its health.
Part one of this series looks at the claims brought against manufacturers of diagnostic test kits.